-
1
-
-
0031968825
-
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
-
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-9.
-
(1998)
Arthritis Rheum.
, vol.41
, pp. 778-9
-
-
Lawrence, R.C.1
Helmick, C.G.2
Arnett, F.C.3
Deyo, R.A.4
Felson, D.T.5
Giannini, E.H.6
Heyse, S.P.7
Hirsch, R.8
Hochberg, M.C.9
-
2
-
-
2942537697
-
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
-
Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572-81.
-
(2004)
N Engl J Med.
, vol.350
, pp. 2572-81
-
-
Edwards, J.C.1
Szczepanski, L.2
Szechinski, J.3
Filipowicz-Sosnowska, A.4
Emery, P.5
Close, D.R.6
Stevens, R.M.7
Shaw, T.8
-
3
-
-
0024779351
-
Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis
-
Pincus T, Callahan LF. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis. Scand J Rheumatol Suppl. 1989;79:67-96.
-
(1989)
Scand J Rheumatol Suppl.
, vol.79
, pp. 67-96
-
-
Pincus, T.1
Callahan, L.F.2
-
4
-
-
47249153519
-
Role of cytokines in rheumatoid arthritis: An education in pathophysiology and therapeutics
-
Feldmann M, Maini RNS. Role of cytokines in rheumatoid arthritis: An education in pathophysiology and therapeutics. Immunol Rev. 2008;223:7-19.
-
(2008)
Immunol Rev.
, vol.223
, pp. 7-19
-
-
Feldmann, M.1
Maini, R.N.S.2
-
5
-
-
0030819475
-
ICAM-1/LFA-1 expression in acute osteodestructive joint lesions in collagen-induced arthritis in rats
-
Seidel MF, Keck R, Vetter H. ICAM-1/LFA-1 expression in acute osteodestructive joint lesions in collagen-induced arthritis in rats. J Histochem Cytochem. 1997;45:1247-53.
-
(1997)
J Histochem Cytochem.
, vol.45
, pp. 1247-53
-
-
Seidel, M.F.1
Keck, R.2
Vetter, H.3
-
6
-
-
27744514865
-
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
-
Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJSM, Hazes JMW, Zwinderman AH, Ronday HK, Han KH, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum. 2005;52:3381-90.
-
(2005)
Arthritis Rheum.
, vol.52
, pp. 3381-90
-
-
Goekoop-Ruiterman, Y.P.1
De Vries-Bouwstra, J.K.2
Allaart, C.F.3
Van Zeben, D.4
Kerstens, P.J.S.M.5
Hazes, J.M.W.6
Zwinderman, A.H.7
Ronday, H.K.8
Han, K.H.9
-
7
-
-
0037203464
-
Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer
-
Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002;113 Suppl 9B:S71-88.
-
(2002)
Am J Med.
, vol.113
, Issue.SUPPL. 9B
-
-
Kris-Etherton, P.M.1
Hecker, K.D.2
Bonanome, A.3
Coval, S.M.4
Binkoski, A.E.5
Hilpert, K.F.6
Griel, A.E.7
Etherton, T.D.8
-
8
-
-
0037210695
-
Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides
-
Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60: 258-74.
-
(2002)
Appl Microbiol Biotechnol.
, vol.60
, pp. 258-74
-
-
Wasser, S.P.1
-
9
-
-
33745439991
-
Inotilone and related phenylpropanoid polyketides from Inonotus sp. and their identification as potent COX and XO inhibitors
-
Wangun KVH, Härtl A, Kiet TT, Hertweck C. Inotilone and related phenylpropanoid polyketides from Inonotus sp. and their identification as potent COX and XO inhibitors. Org Biomol Chem. 2006;4:2545-8.
-
(2006)
Org Biomol Chem.
, vol.4
, pp. 2545-8
-
-
Wangun, K.V.H.1
Härtl, A.2
Kiet, T.T.3
Hertweck, C.4
-
10
-
-
60349104929
-
Effect of an extract based on the medicinal mushroom agaricus blazei murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo
-
Johnson E, Førland DT, Saetre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroom agaricus blazei murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scand J Immunol. 2009;69:242-50.
-
(2009)
Scand J Immunol.
, vol.69
, pp. 242-50
-
-
Johnson, E.1
Førland, D.T.2
Saetre, L.3
Bernardshaw, S.V.4
Lyberg, T.5
Hetland, G.6
-
12
-
-
0017375321
-
Report of the american institute of nutrition ad Hoc committee on standards for nutritional studies
-
Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr. 1977;107:1340-8.
-
(1977)
J Nutr.
, vol.107
, pp. 1340-8
-
-
-
13
-
-
0036128321
-
The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content
-
Murata Y, Shimamura T, Tahami T, Takatsuki T, Hamuro J. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol. 2002;2:673-89.
-
(2002)
Int Immunopharmacol.
, vol.2
, pp. 673-89
-
-
Murata, Y.1
Shimamura, T.2
Tahami, T.3
Takatsuki, T.4
Hamuro, J.5
-
14
-
-
34249779558
-
Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice
-
Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN. Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J Nutr. 2007;137:1472-7.
-
(2007)
J Nutr.
, vol.137
, pp. 1472-7
-
-
Wu, D.1
Pae, M.2
Ren, Z.3
Guo, Z.4
Smith, D.5
Meydani, S.N.6
-
15
-
-
0029553672
-
Collagen-induced arthritis in mice: Synergistic effect of E. coli lipopolysaccharide bypasses epitope. Specificity in the induction of arthritis with monoclonal antibodies to type II collagen
-
Terato K, Harper DS, Griffiths MM, Hasty DL, Ye XJ, Cremer MA, Seyer JM. Collagen-induced arthritis in mice: Synergistic effect of E. coli lipopolysaccharide bypasses epitope. Specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity. 1995;22:137-47.
-
(1995)
Autoimmunity.
, vol.22
, pp. 137-47
-
-
Terato, K.1
Harper, D.S.2
Griffiths, M.M.3
Hasty, D.L.4
Ye, X.J.5
Cremer, M.A.6
Seyer, J.M.7
-
16
-
-
0001768463
-
Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice
-
Caccese RG, Zimmerman JL, Carlson RP. Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflamm. 1992;1:273-9.
-
(1992)
Mediators Inflamm.
, vol.1
, pp. 273-9
-
-
Caccese, R.G.1
Zimmerman, J.L.2
Carlson, R.P.3
-
17
-
-
67349154441
-
Differential effects of isoflurane and CO2 inhalation on plasma levels of inflammatory markers associated with collagen-induced arthritis in DBA mice
-
Lawrance CC, Lucas EA, Clarke SL, Smith BJ, Kuvibidila S. Differential effects of isoflurane and CO2 inhalation on plasma levels of inflammatory markers associated with collagen-induced arthritis in DBA mice. Int Immunopharmacol. 2009;9:807-9.
-
(2009)
Int Immunopharmacol.
, vol.9
, pp. 807-9
-
-
Lawrance, C.C.1
Lucas, E.A.2
Clarke, S.L.3
Smith, B.J.4
Kuvibidila, S.5
-
18
-
-
0029875804
-
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra
-
Joosten LA, Helsen MM, van de Loo FA, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum. 1996;39:797-809.
-
(1996)
Arthritis Rheum.
, vol.39
, pp. 797-809
-
-
Joosten, L.A.1
Helsen, M.M.2
Van De Loo, F.A.3
Van Den Berg, W.B.4
-
19
-
-
0030631403
-
Collagen-induced arthritis, an animal model of autoimmunity
-
Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997;61:1861-72.
-
(1997)
Life Sci.
, vol.61
, pp. 1861-72
-
-
Myers, L.K.1
Rosloniec, E.F.2
Cremer, M.A.3
Kang, A.H.4
-
20
-
-
68649119081
-
Expression of ICAM- 1 and VCAM-1 serum levels in rheumatoid arthritis clinical activity: Association with genetic polymorphisms
-
Navarro-Hernandez RE, Oregon-Romeno E, Mercado MVD, Rangel- Villalobos H, Palafox-Sanchez, Mufioz-Valle JF. Expression of ICAM- 1 and VCAM-1 serum levels in rheumatoid arthritis clinical activity: Association with genetic polymorphisms. Dis Markers. 2009;26:119-26.
-
(2009)
Dis Markers.
, vol.26
, pp. 119-26
-
-
Navarro-Hernandez, R.E.1
Oregon-Romeno, E.2
Mercado, M.V.D.3
Rangel- Villalobos, H.4
Palafox-Sanchez Mufioz-Valle, J.F.5
-
22
-
-
0036694589
-
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
-
Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357-68.
-
(2002)
Cytokine Growth Factor Rev.
, vol.13
, pp. 357-68
-
-
Ishihara, K.1
Hirano, T.2
-
23
-
-
0025260903
-
Interleukin-6: An overview
-
Van Snick J. Interleukin-6: An overview. Annu Rev Immunol. 1990; 8:253-78.
-
(1990)
Annu Rev Immunol.
, vol.8
, pp. 253-78
-
-
Van Snick, J.1
-
24
-
-
0032518415
-
IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
-
Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311-20.
-
(1998)
J Clin Invest.
, vol.101
, pp. 311-20
-
-
Xing, Z.1
Gauldie, J.2
Cox, G.3
Baumann, H.4
Jordana, M.5
Lei, X.F.6
Achong, M.K.7
-
25
-
-
0035139890
-
Interleukin-6 deficiency increases inflammatory bone destruction
-
Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun. 2001;69:744-50.
-
(2001)
Infect Immun.
, vol.69
, pp. 744-50
-
-
Balto, K.1
Sasaki, H.2
Stashenko, P.3
-
26
-
-
0030794222
-
Interleukin-6 reduces cartilage destruction during experimental arthritis: A study in interleukin-6-deficient mice
-
Van de Loo FA, Kuiper S, van Enckevort FH, Antz OJ, van der Berg WB. Interleukin-6 reduces cartilage destruction during experimental arthritis: A study in interleukin-6-deficient mice. Am J Pathol. 1997;151: 177-91.
-
(1997)
Am J Pathol.
, vol.151
, pp. 177-91
-
-
Van De Loo, F.A.1
Kuiper, S.2
Van Enckevort, F.H.3
Antz, O.J.4
Van Der Berg, W.B.5
-
27
-
-
0030823183
-
IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
-
Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol Today. 1997;18:428-33.
-
(1997)
Immunol Today.
, vol.18
, pp. 428-33
-
-
Tilg, H.1
Dinarello, C.A.2
Mier, J.W.3
-
28
-
-
0029842020
-
Induction of cytokines and ICAM-1 by pro-inflammatory: Induction of cytokines and ICAM-1 by pro-inflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin
-
Sakurada S, Kato T, Okamoto T. Induction of cytokines and ICAM-1 by pro-inflammatory: Induction of cytokines and ICAM-1 by pro-inflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Intern Immunol. 1996;8:1483-93.
-
(1996)
Intern Immunol.
, vol.8
, pp. 1483-93
-
-
Sakurada, S.1
Kato, T.2
Okamoto, T.3
-
29
-
-
27644479269
-
TNF-alpha and pathologic bone resorption
-
Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O'Keefe RJ, Xing L. TNF-alpha and pathologic bone resorption. Keio J Med. 2005;54:127-31.
-
(2005)
Keio J Med.
, vol.54
, pp. 127-31
-
-
Boyce, B.F.1
Li, P.2
Yao, Z.3
Zhang, Q.4
Badell, I.R.5
Schwarz, E.M.6
O'Keefe, R.J.7
Xing, L.8
-
30
-
-
0022815786
-
Normal and pathological remodeling of human trabecular bone: Three-dimensional reconstruction of the remodeling sequence in normal and in metabolic bone disease
-
Eriksen EF. Normal and pathological remodeling of human trabecular bone: Three-dimensional reconstruction of the remodeling sequence in normal and in metabolic bone disease. Endocr Rev. 1986;7:379-408.
-
(1986)
Endocr Rev.
, vol.7
, pp. 379-408
-
-
Eriksen, E.F.1
-
31
-
-
33749009030
-
Mechanisms of disease: The link between RANKL and arthritic bone disease
-
Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS. Mechanisms of disease: The link between RANKL and arthritic bone disease. Nature Clin Pract Rheumatol. 2005;1:47-54.
-
(2005)
Nature Clin Pract Rheumatol.
, vol.1
, pp. 47-54
-
-
Schett, G.1
Hayer, S.2
Zwerina, J.3
Redlich, K.4
Smolen, J.S.5
-
32
-
-
34547436716
-
TNF-induced structural joint damage is mediated by IL-1
-
Zwerina J, Redlich K, Polzer K, Joosten L, Krönke G, Distler J, Hess A, Pundt N, Pap T, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA. 2007;104:11742-7.
-
(2007)
Proc Natl Acad Sci USA.
, vol.104
, pp. 11742-7
-
-
Zwerina, J.1
Redlich, K.2
Polzer, K.3
Joosten, L.4
Krönke, G.5
Distler, J.6
Hess, A.7
Pundt, N.8
Pap, T.9
-
33
-
-
40949138343
-
Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis
-
Kanbe K, Inoue K, Inoue Y, Suzuki Y. Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis. Clin Rheumatol. 2008;27:497-501.
-
(2008)
Clin Rheumatol.
, vol.27
, pp. 497-501
-
-
Kanbe, K.1
Inoue, K.2
Inoue, Y.3
Suzuki, Y.4
|